Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of BAY 2433334 after acute myocardial infarction
2019-003244-79Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) and cardiac morbidity comparing BAY 2433334 + dual antiplatelet therapy with Placebo + dual antiplatelet therapy (2 arms). Started Dec 2019; status: completed.
02
Drugs
asundexian
03
Conditions
myocardial infarction (MI)cardiac morbidity
Beyond the preview
Go deeper on 2019-003244-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003244-79.